Journal of the Chemical Society - Faraday Transactions p. 1015 - 1022 (1994)
Update date:2022-08-24
Topics:
Aas, Nina
Pringle, Thomas J.
Bowker, Michael
The adsorptive and reactive behaviour of TiO2, SrTiO3 and SrO towards methanol have been investigated using temperature-programmed desorption and XPS.TiO2 was found to be reduced during the adsorption/desorption process and showed predominantly CH4 formation at low coverages.At higher coverages, alternative paths led also to the desorption of CH3OH and HCHO though CH4 was the main product desorbed at ca. 500 K.The product pattern indicates that a methoxy is the major surface intermediate.CO and H2 were evolved at ca. 600 K, possibly from the decomposition of a formate species, while H2O was desorbed between 300 and 700 K.On SrO the coincident evolution of CO and H2 at 580 K, with H2O and CO2 being minor products, indicated a formate intermediate as the dominant one on this surface.The product pattern on SrTiO3 resembled that on TiO2, although the main product in this case was CH3OH, with CH4 being produced in much smaller quantities and only at much higher temperature than on TiO2 (620 K).The source of these differences is discussed in terms of the detect chemistry of the surface involved.
Contact:0086 533 2282832
Address:Zibo，Shandong
Tianjin Dongchang Fine Chemical Industry Co., Ltd.
Contact:+86-22-29894595
Address:Economic Developing Zone, Ji County, Tianjin, China
website:http://www.weichichem.com
Contact:+8613912949432
Address:Fine Chemical Industrial Base,Wujiang town,He County,Anhui China.
Linyi Shengxin Pharmaceutical R&D Co., Ltd
Contact:+86-18653953873
Address:West First of Yufeng Road, Yishui County
WUXI HONOR SHINE CHEMICAL CO.,LTD
Contact:+86-510-83593312
Address:No.1699 Huishan avenue,Huishan district,Wuxi ,Jiangsu,China,214177.(Wuxi Huishan Ecomonic Develop Zone )
Doi:10.1016/j.phytol.2016.08.005
(2016)Doi:10.1016/j.molcata.2014.06.041
(2014)Doi:10.1016/S0022-1139(00)82059-X
(1987)Doi:10.1002/adsc.200404195
(2004)Doi:10.1021/ol0362919
(2004)Doi:10.1016/j.ijpharm.2014.04.007
(2014)
